Famciclovir in treatment of acute herpes zoster: results of two post-marketing surveillance studies in Germany.
Engst
R
R
Schiewe
U
U
Höbel
W
W
Machka
K
K
Meister
W
W
D015075:2-Aminopurine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000998:Antiviral Agents / Q000008:administration & dosage*; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D000077595:Famciclovir; D005260:Female; D005858:Germany; D006562:Herpes Zoster / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011358:Product Surveillance, Postmarketing; D011379:Prognosis; D011446:Prospective Studies; D016896:Treatment Outcome
D000998:Antiviral Agents; D015075:2-Aminopurine; D000077595:Famciclovir